Unknown

Dataset Information

0

The vitamin D for COVID-19 (VIVID) trial: A pragmatic cluster-randomized design.


ABSTRACT:

Objectives

To determine the effect of vitamin D supplementation on disease progression and post-exposure prophylaxis for COVID-19 infection. We hypothesize that high-dose vitamin D3 supplementation will reduce risk of hospitalization/death among those with recently diagnosed COVID-19 infection and will reduce risk of COVID-19 infection among their close household contacts.

Methods

We report the rationale and design of a planned pragmatic, cluster randomized, double-blinded trial (N = 2700 in total nationwide), with 1500 newly diagnosed individuals with COVID-19 infection, together with up to one close household contact each (~1200 contacts), randomized to either vitamin D3 (loading dose, then 3200 IU/day) or placebo in a 1:1 ratio and a household cluster design. The study duration is 4 weeks. The primary outcome for newly diagnosed individuals is the occurrence of hospitalization and/or mortality. Key secondary outcomes include symptom severity scores among cases and changes in the infection (seroconversion) status for their close household contacts. Changes in vitamin D 25(OH)D levels will be assessed and their relation to study outcomes will be explored.

Conclusions

The proposed pragmatic trial will allow parallel testing of vitamin D3 supplementation for early treatment and post-exposure prophylaxis of COVID-19. The household cluster design provides a cost-efficient approach to testing an intervention for reducing rates of hospitalization and/or mortality in newly diagnosed cases and preventing infection among their close household contacts.

SUBMITTER: Wang R 

PROVIDER: S-EPMC7547023 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

The vitamin D for COVID-19 (VIVID) trial: A pragmatic cluster-randomized design.

Wang Rui R   DeGruttola Victor V   Lei Quanhong Q   Mayer Kenneth H KH   Redline Susan S   Hazra Aditi A   Mora Samia S   Willett Walter C WC   Ganmaa Davaasambuu D   Manson JoAnn E JE  

Contemporary clinical trials 20201010


<h4>Objectives</h4>To determine the effect of vitamin D supplementation on disease progression and post-exposure prophylaxis for COVID-19 infection. We hypothesize that high-dose vitamin D3 supplementation will reduce risk of hospitalization/death among those with recently diagnosed COVID-19 infection and will reduce risk of COVID-19 infection among their close household contacts.<h4>Methods</h4>We report the rationale and design of a planned pragmatic, cluster randomized, double-blinded trial (  ...[more]

Similar Datasets

| S-EPMC5376219 | biostudies-literature
| S-EPMC7989070 | biostudies-literature
| S-EPMC4226652 | biostudies-literature
| S-EPMC5513078 | biostudies-literature
| S-EPMC7722693 | biostudies-literature
| S-EPMC5836725 | biostudies-literature
| S-EPMC7003172 | biostudies-literature
| S-EPMC8317238 | biostudies-literature
| S-EPMC6493975 | biostudies-literature
| S-EPMC6200520 | biostudies-literature